AAAAAA

   
Results: 1-18 |
Results: 18
DEVELOPMENT OF THE LOGICAL OBSERVATION IDENTIFIER NAMES AND CODES (LOINC) VOCABULARY
Authors: HUFF SM ROCHA RA MCDONALD CJ DEMOOR GJE FIERS T BIDGOOD WD FORREY AW FRANCIS WG TRACY WR LEAVELLE D STALLING F GRIFFIN B MALONEY P LELAND D CHARLES L HUTCHINS K BAENZIGER J
Citation: Sm. Huff et al., DEVELOPMENT OF THE LOGICAL OBSERVATION IDENTIFIER NAMES AND CODES (LOINC) VOCABULARY, Journal of the American Medical Informatics Association, 5(3), 1998, pp. 276-292
DO PSEUDOEPHEDRINE OR PHENYLPROPANOLAMINE IMPROVE MAXIMUM OXYGEN-UPTAKE AND TIME TO EXHAUSTION
Authors: SWAIN RA HARSHA DM BAENZIGER J SAYWELL RM
Citation: Ra. Swain et al., DO PSEUDOEPHEDRINE OR PHENYLPROPANOLAMINE IMPROVE MAXIMUM OXYGEN-UPTAKE AND TIME TO EXHAUSTION, Clinical journal of sport medicine, 7(3), 1997, pp. 168-173
INDUCTION OF CYTOTOXIC T-LYMPHOCYTES BY INTRAMUSCULAR IMMUNIZATION WITH PLASMID DNA IS FACILITATED BY BONE-MARROW-DERIVED CELLS
Authors: DOE B SELBY M BARNETT S BAENZIGER J WALKER CM
Citation: B. Doe et al., INDUCTION OF CYTOTOXIC T-LYMPHOCYTES BY INTRAMUSCULAR IMMUNIZATION WITH PLASMID DNA IS FACILITATED BY BONE-MARROW-DERIVED CELLS, Proceedings of the National Academy of Sciences of the United Statesof America, 93(16), 1996, pp. 8578-8583
LOGICAL OBSERVATION IDENTIFIER NAMES AND CODES (LOINC) DATABASE - A PUBLIC USE SET OF CODES AND NAMES FOR ELECTRONIC REPORTING OF CLINICAL LABORATORY TEST-RESULTS
Authors: FORREY AW MCDONALD CJ DEMOOR G HUFF SM LEAVELLE D LELAND D FIERS T CHARLES L GRIFFIN B STALLING F TULLIS A HUTCHINS K BAENZIGER J
Citation: Aw. Forrey et al., LOGICAL OBSERVATION IDENTIFIER NAMES AND CODES (LOINC) DATABASE - A PUBLIC USE SET OF CODES AND NAMES FOR ELECTRONIC REPORTING OF CLINICAL LABORATORY TEST-RESULTS, Clinical chemistry, 42(1), 1996, pp. 81-90
CLINICAL, IMMUNOLOGICAL, AND VIROLOGICAL OBSERVATIONS RELATED TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-I INFECTION IN A VOLUNTEER IN AN HIV-1 VACCINE CLINICAL-TRIAL
Authors: KAHN JO STEIMER KS BAENZIGER J DULIEGE AM FEINBERG M ELBEIK T CHESNEY M MURCAR N CHERNOFF D SINANGIL F
Citation: Jo. Kahn et al., CLINICAL, IMMUNOLOGICAL, AND VIROLOGICAL OBSERVATIONS RELATED TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-I INFECTION IN A VOLUNTEER IN AN HIV-1 VACCINE CLINICAL-TRIAL, The Journal of infectious diseases, 171(5), 1995, pp. 1343-1347
LACK OF ASSOCIATION BETWEEN ANTI-V3 LOOP ANTIBODIES AND PERINATAL TRANSMISSION OF HIV-1 IN KAMPALA, UGANDA
Authors: EPSTEIN H GUAY L HOM D MMIRO F NDUGWA C MARUM L OLNESS K PIWOWAR E KATAAHA P BAENZIGER J JACKSON JB
Citation: H. Epstein et al., LACK OF ASSOCIATION BETWEEN ANTI-V3 LOOP ANTIBODIES AND PERINATAL TRANSMISSION OF HIV-1 IN KAMPALA, UGANDA, Pediatric AIDS and HIV infection, 5(6), 1994, pp. 350-356
PRIMARY ISOLATE NEUTRALIZING ACTIVITY OF HUMAN-ANTIBODIES DIRECTED TORECOMBINANT, NATIVE HIV-SF2 GP120 (RGP120(SF2))
Authors: STEIMER KS SINANGIL F KAHN J CHERNOFF D DULIEGE AM BAENZIGER J
Citation: Ks. Steimer et al., PRIMARY ISOLATE NEUTRALIZING ACTIVITY OF HUMAN-ANTIBODIES DIRECTED TORECOMBINANT, NATIVE HIV-SF2 GP120 (RGP120(SF2)), AIDS research and human retroviruses, 10, 1994, pp. 190000055-190000055
MICROFLUIDIZED OIL-EMULSIONS AS ADJUVANTS FOR HIV AND OTHER HUMAN VACCINES
Authors: VANNEST G WALKER C STEIMER K BAENZIGER J BURKE RL OTT G
Citation: G. Vannest et al., MICROFLUIDIZED OIL-EMULSIONS AS ADJUVANTS FOR HIV AND OTHER HUMAN VACCINES, AIDS research and human retroviruses, 10, 1994, pp. 190000115-190000115
ONE-YEAR FOLLOW-UP OF A PHASE-1 STUDY OF HIV-1 GP120 VACCINE COMBINEDWITH MF59 AND WITH A DOSE-ESCALATION OF MTP-PE IN HIV-1 NONINFECTED ADULTS
Authors: KAHN J CHERNOFF D SINANGIL F BAENZIGER J MURCAR N COLEMAN R WYNNE D LEE D HESTERMAN K SAKAMOTO D CUISON G DEKKER C STEIMER KS
Citation: J. Kahn et al., ONE-YEAR FOLLOW-UP OF A PHASE-1 STUDY OF HIV-1 GP120 VACCINE COMBINEDWITH MF59 AND WITH A DOSE-ESCALATION OF MTP-PE IN HIV-1 NONINFECTED ADULTS, AIDS research and human retroviruses, 10, 1994, pp. 190000155-190000155
COMPARATIVE SAFETY AND VACCINE IMMUNOGENICITY OF YEAST-DERIVED, DENATURED, NONGLYCOSYLATED HIV-1 SF2 GP120 (ENV-2-3) VS CHO-DERIVED, CONFORMATIONALLY INTACT GLYCOSYLATED GP120 IN HIV-1 SEROPOSITIVE SUBJECTS
Authors: CHERNOFF D LANG W SINANGIL F BAENZIGER J STEINER K DEKKER C
Citation: D. Chernoff et al., COMPARATIVE SAFETY AND VACCINE IMMUNOGENICITY OF YEAST-DERIVED, DENATURED, NONGLYCOSYLATED HIV-1 SF2 GP120 (ENV-2-3) VS CHO-DERIVED, CONFORMATIONALLY INTACT GLYCOSYLATED GP120 IN HIV-1 SEROPOSITIVE SUBJECTS, AIDS research and human retroviruses, 10, 1994, pp. 190000157-190000157
MAPPING OF B-CELL AND T-CELL RESPONSES OF HIV-1 SERONEGATIVE INDIVIDUALS VACCINATED WITH RECOMBINANT HIV-SF2 GP120
Authors: STEIMER KS SINANGIL F BAENZIGER J KAHN J DINA D
Citation: Ks. Steimer et al., MAPPING OF B-CELL AND T-CELL RESPONSES OF HIV-1 SERONEGATIVE INDIVIDUALS VACCINATED WITH RECOMBINANT HIV-SF2 GP120, AIDS research and human retroviruses, 10, 1994, pp. 190000047-190000047
HEREDITARY VARIATIONS IN MONOAMINE-OXIDASE AS A RISK FACTOR FOR PARKINSONS-DISEASE
Authors: HOTAMISLIGIL GS GIRMEN AS FINK JS TIVOL E SHALISH C TROFATTER J BAENZIGER J DIAMOND S MARKHAM C SULLIVAN J GROWDON J BREAKEFIELD XO
Citation: Gs. Hotamisligil et al., HEREDITARY VARIATIONS IN MONOAMINE-OXIDASE AS A RISK FACTOR FOR PARKINSONS-DISEASE, Movement disorders, 9(3), 1994, pp. 305-310
CLINICAL AND IMMUNOLOGICAL RESPONSES TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE 1(SF2) GP120 SUBUNIT VACCINE COMBINED WITH MF59 ADJUVANT WITH OR WITHOUT MURAMYL TRIPEPTIDE DIPALMITOYL PHOSPHATIDYLETHANOLAMINE IN NON-HIV-INFECTED HUMAN VOLUNTEERS
Authors: KAHN JO SINANGIL F BAENZIGER J MURCAR N WYNNE D COLEMAN RL STEIMER KS DEKKER CL CHERNOFF D
Citation: Jo. Kahn et al., CLINICAL AND IMMUNOLOGICAL RESPONSES TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE 1(SF2) GP120 SUBUNIT VACCINE COMBINED WITH MF59 ADJUVANT WITH OR WITHOUT MURAMYL TRIPEPTIDE DIPALMITOYL PHOSPHATIDYLETHANOLAMINE IN NON-HIV-INFECTED HUMAN VOLUNTEERS, The Journal of infectious diseases, 170(5), 1994, pp. 1288-1291
PRECLINICAL IMMUNOGENICITY STUDIES IN BABOONS WITH CANDIDATE HIV-1 SUBUNIT VACCINES PREDICT THE HUMAN IMMUNE-RESPONSE
Authors: STEIMER K BAENZIGER J KAHN J VANNEST G CHERNOFF D DEKKER C SINANGIL F
Citation: K. Steimer et al., PRECLINICAL IMMUNOGENICITY STUDIES IN BABOONS WITH CANDIDATE HIV-1 SUBUNIT VACCINES PREDICT THE HUMAN IMMUNE-RESPONSE, AIDS research and human retroviruses, 9, 1993, pp. 190000041-190000041
PROTECTION OF HU-PBL-SCID MICE FROM HIV-1 INFECTION BY PASSIVE-IMMUNIZATION WITH ANTIBODIES FROM BABOONS IMMUNIZED WITH RECOMBINANT GP120 SUBUNIT VACCINES
Authors: BAENZIGER J
Citation: J. Baenziger, PROTECTION OF HU-PBL-SCID MICE FROM HIV-1 INFECTION BY PASSIVE-IMMUNIZATION WITH ANTIBODIES FROM BABOONS IMMUNIZED WITH RECOMBINANT GP120 SUBUNIT VACCINES, AIDS research and human retroviruses, 9, 1993, pp. 190000077-190000077
PHASE-STUDY OF AN HIV-1 GP 120 VACCINE COMBINED WITH THE NOVEL ADJUVANT EMULSION, MF59 AND THE BIOLOGIC RESPONSE MODIFIER MTP-PE IN HIV SERONEGATIVE ADULTS
Authors: KAHN J CHERNOFF D SINANGIL F BAENZIGER J MURCAR N WYNNE D COLEMAN R STEIMER K DEKKER C
Citation: J. Kahn et al., PHASE-STUDY OF AN HIV-1 GP 120 VACCINE COMBINED WITH THE NOVEL ADJUVANT EMULSION, MF59 AND THE BIOLOGIC RESPONSE MODIFIER MTP-PE IN HIV SERONEGATIVE ADULTS, Journal of cellular biochemistry, 1993, pp. 79-79
AN IMPROVED METHOD FOR ASSESSING ANTIBODY-RESPONSES TO THE PRINCIPAL NEUTRALIZING DETERMINANT (PND) OF HIV-1 GP120
Authors: SAKAMOTO D BAENZIGER J SINANGIL F LEE D TURCK C STEIMER K
Citation: D. Sakamoto et al., AN IMPROVED METHOD FOR ASSESSING ANTIBODY-RESPONSES TO THE PRINCIPAL NEUTRALIZING DETERMINANT (PND) OF HIV-1 GP120, Journal of cellular biochemistry, 1993, pp. 85-85
GLUT-4 NH2 TERMINUS CONTAINS A PHENYLALANINE-BASED TARGETING MOTIF THAT REGULATES INTRACELLULAR SEQUESTRATION
Authors: PIPER RC TAI C KULESZA P PANG SH WARNOCK D BAENZIGER J SLOT JW GEUZE HJ PURI C JAMES DE
Citation: Rc. Piper et al., GLUT-4 NH2 TERMINUS CONTAINS A PHENYLALANINE-BASED TARGETING MOTIF THAT REGULATES INTRACELLULAR SEQUESTRATION, The Journal of cell biology, 121(6), 1993, pp. 1221-1232
Risultati: 1-18 |